Oseltamivir Influenza - Drugs in Context S.

Drugs in Context is an independent, peer reviewed and practice orientated review of all the significant data on a specific drug, placed in the context of the disease and clinical practice setting. Oseltamivir; Editorial: "The coming years will see GPs prescribing more of the new anti-influenza drugs in primary care, both in treating the most vulnerable patients and in preventing virus spread in families and elderly residential homes." Disease Overview: "The threat from influenza is greatly increased in those with other chronic underlying medical conditions, particularly cardiovascular disease, diabetes and chronic obstructive pulmonary disease." Drug Review: "Reported benefits of oseltamivir treatment include faster resolution of symptoms such as cough, fever and sore throat, plus a speedier return to good health, normal sleeping patterns and a restoration of activity to pre-illness levels." Improving Practice: "We can only hope that government policy may shift over the coming years to encourage the routine vaccination of more children and adults."